Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 5 (May)

1. Paraneoplastic hypercalcemia with adenosquamous carcinoma of the colon.
   Int J Clin Oncol, 10(2): 144-7. [Abstract] [Full-text]
2. Alphavbeta5-integrins mediate early steps of metastasis formation.
   Eur J Cancer, 41(7): 1065-72. [Abstract] [Full-text]
3. Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer.
   Am J Surg, 189(5): 512-7; discussion 517. [Abstract] [Full-text]
4. Adenocarcinoma after ileoanal anastomosis for familial adenomatous polyposis: review of risk factors and current surveillance apropos of a case.
   J Gastrointest Surg, 9(5): 695-702. [Abstract] [Full-text]
5. Arteriolovenular shunting critically determines shutdown of microcirculation upon cryotherapy in tumor-bearing rat liver.
   Ann Surg Oncol, 12(4): 303-12. [Abstract] [Full-text]
6. Colorectal cancer screening in average risk individuals.
   Cancer Causes Control, 16(2): 171-88. [Abstract] [Full-text]
7. Elucidation of thioredoxin as a molecular target for antitumor quinols.
   Cancer Res, 65(9): 3911-9. [Abstract] [Full-text]
8. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model.
   Cancer Res, 65(9): 3716-25. [Abstract] [Full-text]
9. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
   Mol Cell Endocrinol, 235(1): 21-9. [Abstract] [Full-text]
10. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
    Br J Cancer, 92(9): 1655-62. [Abstract] [Full-text]
11. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.
    Cancer, 103(10): 2163-70. [Abstract] [Full-text]
12. Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability: a study matched for T classification and tumor location.
    Cancer, 103(10): 2023-9. [Abstract] [Full-text]
13. Metastatic testicular carcinoma from the colon with clinical, immunophenotypical, and molecular characterization: report of a case.
    Dis Colon Rectum, 48(3): 582-5. [Abstract] [Full-text]
14. Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis.
    Dis Colon Rectum, 48(3): 567-71. [Abstract] [Full-text]
15. The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenic events in rats.
    Dis Colon Rectum, 48(3): 549-59. [Abstract] [Full-text]
16. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells.
    J Biol Chem, 280(19): 19027-35. [Abstract] [Full-text]
17. Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling.
    Am J Physiol Gastrointest Liver Physiol, 288(6): G1274-82. [Abstract] [Full-text]
18. Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin.
    Cancer Lett, 223(1): 159-67. [Abstract] [Full-text]
19. Associated nutritional risk of breast and colon cancers: a population-based case-control study in Montreal, Canada.
    Cancer Lett, 223(1): 85-91. [Abstract] [Full-text]
20. TGF-beta signaling in colon cancer cells.
    World J Surg, 29(3): 306-11. [Abstract] [Full-text]
21. Tissue-specific attenuation of endogenous DNA I-compounds in rats by carcinogen azoxymethane: possible role of dietary fish oil in colon cancer prevention.
    Cancer Epidemiol Biomarkers Prev, 14(5): 1230-5. [Abstract] [Full-text]
22. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer.
    Cancer Epidemiol Biomarkers Prev, 14(5): 1224-9. [Abstract] [Full-text]
23. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
    Clin Cancer Res, 11(10): 3705-13. [Abstract] [Full-text]
24. In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
    Clin Cancer Res, 11(10): 3633-41. [Abstract] [Full-text]
25. A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing.
    Clin Cancer Res, 11(10): 3614-23. [Abstract] [Full-text]
26. Predictive neural networks for gene expression data analysis.
    Neural Netw, 18(3): 297-306. [Abstract] [Full-text]
27. Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness.
    Cancer Lett, 223(2): 313-22. [Abstract] [Full-text]
28. Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats.
    Cancer Lett, 223(2): 203-9. [Abstract] [Full-text]
29. Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices.
    Bioinformatics, 21(10): 2301-8. [Abstract] [Full-text]
30. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays.
    Int J Cancer, 115(5): 783-9. [Abstract] [Full-text]
31. CpG island methylation in aberrant crypt foci and cancers from the same patients.
    Int J Cancer, 115(5): 747-51. [Abstract] [Full-text]
32. Selective killing of adriamycin-resistant (G2 checkpoint-deficient and MRP1-expressing) cancer cells by docetaxel.
    Cancer Res, 65(10): 4401-7. [Abstract] [Full-text]
33. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis.
    Cancer Res, 65(10): 4261-72. [Abstract] [Full-text]
34. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
    Cancer Res, 65(10): 4228-37. [Abstract] [Full-text]
35. Laparoscopically assisted resection of an ascending colon lipoma causing intermittent intussusception.
    J Laparoendosc Adv Surg Tech A, 15(2): 173-5. [Abstract] [Full-text]
36. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations.
    Int J Cancer, 116(1): 73-7. [Abstract] [Full-text]
37. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells.
    Int J Cancer, 116(1): 52-61. [Abstract] [Full-text]
38. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
    Int J Cancer, 116(1): 9-15. [Abstract] [Full-text]
39. Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin.
    Int J Cancer, 115(6): 924-9. [Abstract] [Full-text]
40. Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth.
    Differentiation, 73(4): 142-53. [Abstract] [Full-text]
41. Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
    Cancer Sci, 96(5): 260-4. [Abstract] [Full-text]
42. Using the gastroscope for incomplete colonoscopy.
    Dis Colon Rectum, 48(4): 851-4. [Abstract] [Full-text]
43. Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis.
    Dis Colon Rectum, 48(4): 816-23. [Abstract] [Full-text]
44. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line.
    Mol Carcinog, 43(2): 65-74. [Abstract] [Full-text]
45. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.
    Mod Pathol, 18(6): 816-21. [Abstract] [Full-text]
46. The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment.
    Cancer Lett, 224(1): 111-6. [Abstract] [Full-text]
47. Equivocal impact of transplacental and lactational exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, on prostate and colon lesion development in F344 rats.
    Cancer Lett, 224(1): 23-30. [Abstract] [Full-text]
48. Factors associated with colon cancer screening: the role of patient factors and physician counseling.
    Prev Med, 41(1): 23-9. [Abstract] [Full-text]
49. Setting educational priorities for women's preventive health: measuring beliefs about screening across disease states.
    J Womens Health (Larchmt), 14(4): 324-30. [Abstract] [Full-text]
50. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
    J Clin Oncol, 23(16): 3713-7. [Abstract] [Full-text]
51. Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines.
    Cancer Lett, 225(1): 61-74. [Abstract] [Full-text]
52. Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability.
    Int J Cancer, 116(2): 322-6. [Abstract] [Full-text]
53. Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products.
    Int J Cancer, 116(2): 236-42. [Abstract] [Full-text]
54. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8.
    Int J Cancer, 116(2): 275-81. [Abstract] [Full-text]
55. Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.
    Int J Cancer, 116(2): 304-13. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.